Key result
Klebsiella aerogenes vaccination cuts aortic plaque burden ~40% in preclinical atherosclerosis.
Why the study?
Does a microbiota-targeted vaccine against Klebsiella aerogenes reduce aortic atherosclerotic plaque burden and preserve serum estradiol levels in ApoE-knockout mice fed a high-fat diet?
Does a microbiota-targeted vaccine against Klebsiella aerogenes reduce aortic atherosclerotic plaque burden and preserve serum estradiol levels in ApoE-knockout mice fed a high-fat diet?
Answers are grounded in this paper and cite their sources.
Identifies endothelial SYNPO2/VNN1 dysregulation and Klebsiella aerogenes-mediated estradiol degradation as drivers of atherosclerosis, demonstrating in mice that a K. aerogenes vaccine preserves estradiol and reduces plaque burden by ~40%.
Background Gut microbiota (GM) dysbiosis is implicated in atherosclerosis (AS), but its causal mechanisms and actionable therapeutic targets remain elusive. This study aims to identify specific GM-host interactions and translate multiomics findings into clinically relevant therapeutic strategies. Methods We developed an integrative multiomics framework combining bidirectional Mendelian randomization (MR) on large-scale GWAS data, bulk and single-cell transcriptomics, and in vivo validation. MR was used to identify causal microbial taxa. Transcriptomic analyses revealed key endothelial genes. A microbiota-targeted vaccine against Klebsiella aerogenes was developed and tested in ApoE-knockout mice fed a high-fat diet to evaluate its therapeutic efficacy on plaque burden, lipid profiles, and hormonal levels. Results Bidirectional MR identified 38 microbial taxa causally linked to AS (14 risk-enhancing and 24 protective). Integrative transcriptomics pinpointed SYNPO2 (downregulated) and VNN1 (upregulated) as key endothelial genes in AS progression. Single-cell RNA sequencing further defined endothelial cells as central mediators, with SYNPO2 dominating early differentiation and VNN1 driving late-stage inflammation. Drug screening identified estradiol and progesterone as dual-target agents. Notably, K. aerogenes was found to degrade atheroprotective estradiol. Vaccination against K. aerogenes preserved serum estradiol levels, reduced aortic plaque burden by approximately 40%, and improved lipid profiles in mice without disrupting overall gut microbial diversity. Conclusions This study defines a SYNPO2-VNN1 dysregulation axis in endothelial cells as a key driver of AS, exacerbated by GM-mediated estradiol depletion. The K. aerogenes -targeted vaccine represents a novel, precision-based therapeutic approach that preserves vasoprotective estradiol and attenuates atherosclerosis. Our findings establish the GM-immune-endothelial axis as a promising and clinically translatable target for precision cardiology, offering new strategies beyond traditional lipid-centered therapies.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied Atherosclerosis (n=10). Klebsiella aerogenes-targeted vaccine (1 × 10^7 freeze-dried bacterial cells/mouse with curdlan/CpG-ODN in incomplete Freund's adjuvant) vs. Adjuvant control (curdlan combined with CpG-ODN emulsions in incomplete Freund's adjuvant without antigen) was evaluated on Aortic atherosclerotic plaque burden (percentage of plaque occupancy relative to total vascular area) (Approximately 40% relative reduction). Vaccination against Klebsiella aerogenes reduced aortic plaque burden by approximately 40% and preserved serum estradiol levels in ApoE-knockout mice fed a high-fat diet.
Synapse has enriched 10 related papers. Consider them for comparative context: